| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |